 (continued from above) The HPV Vaccine is Cancer Prevention
HPV is responsible for 91% of cervical cancer cases in the United States. Although cervical cancer is preventable through regular screening and vaccination, there were approximately 14,100 new cases of cervical cancer in the United States in 2022.
HPV is spread from skin-to-skin contact during sexual activity with someone who has it. The most commonly noticeable symptom developed from an HPV infection is genital warts. However, most people with HPV develop no symptoms, so it can be difficult to detect. An abnormal result from a Pap smear test, a procedure to test for cervical cancer in women, may be the first sign that a woman has the virus. While screening can detect early signs of cervical cancer, other cancers caused by HPV do not have recommended screenings.
The HPV vaccine, known as Gardasil 9, is the best way to protect against infection from the strains of HPV that are most harmful. Data shows that HPV infections, genital warts, and cervical precancers have considerably decreased since the vaccine has been in use in the United States.
The HPV vaccine can help protect children against 6 types of cancer later in life:
- Cancers of the cervix, throat, vagina, vulva, and anus in females
- Cancers of the throat, penis, and anus in males
For the best protection against HPV related cancers, early vaccination is recommended. The CDC's recommendations for HPV vaccine use are as follows:
- HPV vaccination is recommended for boys and girls at ages 11-12. HPV vaccines can be given starting at age 9. The CDC recommends that 11-12-year-olds receive two doses of HPV vaccine 6 to 12 months apart.
- Teens and young adults who start the series later, at ages 15-26, need three doses of HPV vaccine.
- Vaccination is not recommended for everyone older than age 26. Speak with your doctor to see if the vaccine is right for you.
|